You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Chromophobe Renal Cell Carcinoma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Kidney Cancer, Renal Cell Carcinoma, Clear Cell Carcinoma Trial in Dallas (13C-Glucose, 13C-Acetate, 13C-Lactate)

Recruiting
  • Kidney Cancer
  • +11 more
  • 13C-Glucose
  • +4 more
  • Dallas, Texas
    University of Texas Southwestern Medical Center
Dec 1, 2022

Advanced or Metastatic Non-clear Cell Renal Cell Carcinoma, Unclassified Renal Cell Carcinoma, Papillary Renal Cell Carcinoma

Recruiting
  • Advanced or Metastatic Non-clear Cell Renal Cell Carcinoma
  • +6 more
  • Basking Ridge, New Jersey
  • +6 more
Feb 2, 2022

Renal Cell Carcinoma, Papillary Renal Cell Carcinoma Type 1, Papillary Renal Cell Carcinoma Type 2 Trial in Australia

Recruiting
  • Renal Cell Carcinoma
  • +5 more
  • Albury, New South Wales, Australia
  • +10 more
Feb 14, 2022

Renal Cell Carcinoma, Papillary Renal Cell Carcinoma Type 1, Papillary Renal Cell Carcinoma Type 2 Trial in Australia

Active, not recruiting
  • Renal Cell Carcinoma
  • +5 more
  • Albury, New South Wales, Australia
  • +18 more
Feb 14, 2022

Advanced Renal Cell Carcinoma, Chromophobe Renal Cell Carcinoma, Clear Cell Renal Cell Carcinoma Trial in United States (drug,

Recruiting
  • Advanced Renal Cell Carcinoma
  • +8 more
  • Cabozantinib S-malate
  • +3 more
  • Birmingham, Alabama
  • +35 more
Jan 24, 2023

Non-clear Renal Cell Carcinoma Trial in Nanjing, Nanning (Toripalimab, Axitinib)

Recruiting
  • Non-clear Renal Cell Carcinoma
  • Nanjing, Jiangsu, China
  • +1 more
Mar 13, 2023

Biomarkers of Renal Cancer

Recruiting
  • Renal Cell Carcinoma
  • +3 more
    • Firenze, Italy
    • +3 more
    Mar 14, 2023

    Delving Into Participation Trends in Renal Cell Carcinoma

    Not yet recruiting
    • Renal Cell Carcinoma
      • San Francisco, California
        Power Life Sciences
      Oct 16, 2023

      Renal Cell Carcinoma Trial in Beijing (68Ga-NY104 PET/CT)

      Recruiting
      • Renal Cell Carcinoma
      • 68Ga-NY104 PET/CT
      • Beijing, Beijing, China
        Peking Union Medical College Hospital
      Jun 5, 2023

      Moesin Expression in Clear Cell Renal Cell Carcinoma

      Completed
      • Renal Cell Carcinoma
      • Immunohistochemical detection of Moesin in Clear cell Renal Cell Carcinoma
      • (no location specified)
      Sep 20, 2023

      Renal Cell Carcinoma Trial (Sunitinib)

      Not yet recruiting
      • Renal Cell Carcinoma
      • (no location specified)
      Sep 11, 2023

      ccRCC, Clear Cell Renal Cell Carcinoma, Kidney Cancer Trial (NKT2152, palbociclib, sasanlimab)

      Not yet recruiting
      • ccRCC
      • +20 more
      • (no location specified)
      Jul 6, 2023

      Clear Cell Renal Cell Carcinoma Trial in Beijing (68Ga-NY104 PET/CT)

      Not yet recruiting
      • Clear Cell Renal Cell Carcinoma
      • 68Ga-NY104 PET/CT
      • Beijing, Beijing, China
        Peking Union Medical College Hospital
      May 18, 2023

      Metastatic Clear Cell Renal Cell Carcinoma Trial in Beijing (68Ga-NY104 PET/CT)

      Not yet recruiting
      • Metastatic Clear Cell Renal Cell Carcinoma
      • 68Ga-NY104 PET/CT
      • Beijing, Beijing, China
        Peking Union Medical College Hospital
      May 18, 2023

      Clear Cell Renal Cell Carcinoma Trial in Los Angeles (89Zr-DFO-girentuximab)

      Available
      • Clear Cell Renal Cell Carcinoma
      • 89Zr-DFO-girentuximab
      • Los Angeles, California
        UCLA
      Oct 12, 2023

      Clear Cell Renal Cell Carcinoma Trial in Beijing (68Ga-NY104 PET/CT)

      Not yet recruiting
      • Clear Cell Renal Cell Carcinoma
      • 68Ga-NY104 PET/CT
      • Beijing, Beijing, China
        Peking Union Medical College Hospital
      May 28, 2023

      Clear Cell Renal Cell Carcinoma?Resistance to Immunotherapy Trial in Shanghai (AK104(anti-PD-1/CTLA-4 bi-specific antibody

      Recruiting
      • Clear Cell Renal Cell Carcinoma、Resistance to Immunotherapy
      • AK104（anti-PD-1/CTLA-4 bi-specific antibody ，intravenously）,lenvatinib（ targeted VEGFR 1-3、FGFR、PDGFRα， small molecule TKI，orally
      • Shanghai, Shanghai, China
        Shanghai Renji Hospital
      Sep 12, 2023

      Clear Cell Renal Cell Carcinoma, Suspected Recurrent Renal Clear Cell Carcinoma, Recurrent Renal Cell Cancer Trial

      Not yet recruiting
      • Clear Cell Renal Cell Carcinoma
      • +2 more
      • (no location specified)
      May 14, 2023

      Advanced Renal Cell Carcinoma Trial in Beijing (ST-1898 tablets)

      Recruiting
      • Advanced Renal Cell Carcinoma
      • ST-1898 tablets
      • Beijing, Beijing, China
        Peking University Cancer Hospital & Institute
      Nov 6, 2023

      Renal Cell Carcinoma Trial (HS-10516)

      Not yet recruiting
      • Renal Cell Carcinoma
      • (no location specified)
      Sep 24, 2023

      Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma, Kidney Cancer Trial in Boston (Implantable Microdevice (IMD))

      Not yet recruiting
      • Renal Cell Carcinoma
      • +2 more
      • Implantable Microdevice (IMD)
      • Boston, Massachusetts
        Dana-Farber Cancer Institute
      Jan 17, 2023

      Renal Cell Carcinoma Trial in Birmingham (Pembrolizumab injection)

      Not yet recruiting
      • Renal Cell Carcinoma
      • Pembrolizumab injection
      • Birmingham, Alabama
        University of Alabama at Birmingham
      Aug 20, 2023

      Renal Cell Carcinoma Trial in Tabriz (Sodium Pentaborate)

      Not yet recruiting
      • Renal Cell Carcinoma
      • Sodium Pentaborate
      • Tabriz, East Azarbayejan, Iran, Islamic Republic of
        Imam Reza hospital and Clinic of Salamat
      Mar 23, 2023

      Papillary Renal Cell Carcinoma Trial (Pembrolizumab, Placebo)

      Not yet recruiting
      • Papillary Renal Cell Carcinoma
      • (no location specified)
      Nov 24, 2023

      Renal Cell Carcinoma Trial in Guangzhou (Pucotenlimab Combined With Lenvatinib)

      Not yet recruiting
      • Renal Cell Carcinoma
      • Pucotenlimab Combined With Lenvatinib
      • Guangzhou, Other (Non U.s.), China
        Sun Yat-sen University Cancer Center
      Nov 10, 2023